By the source of the data can be divided into internal collection of data, third-party data collection of two aspects, for the two types of data use each enterprise according to their own stage of enterprise development, product cycle, market demand, hospital data CPA is the earlier engaged in the collection of data on hospitals in the country's organizations, samples: collection of data from 400-500 hospitals across the country, the principle of statistics: the original data of the sample, the keyword Segment:Time, product name, manufacturer, specifications, dosage form, quantity, amount 4, characteristics:National key hospital drug sales of Western medicines mainly, the application of the data:Specific hospital level performance of the target product; changes in market share in different hospitals; different levels of hospitals/market types of competition comparison; hospital potential assessment and single production.
:
I. The pharmaceutical industry is an important part of China's national economy, is a combination of traditional and modern industries, primary, secondary and tertiary industries as a whole. Its main categories include: chemical raw materials and preparations, Chinese herbal medicines, Chinese medicine, Chinese medicine tablets, proprietary Chinese medicines, antibiotics, biological products, biochemical drugs, radiopharmaceuticals, medical equipment, sanitary materials, pharmaceutical machinery, pharmaceutical packaging materials and pharmaceutical business. Pharmaceutical industry for the protection and enhancement of people's health, improve the quality of life, for family planning, disaster relief and epidemic prevention, military preparedness, as well as to promote economic development and social progress has a very important role.
Second, in 2000, the pharmaceutical industry (English expression: Medical Industry) completed the total output value of 233.2 billion yuan, an average annual growth rate of 17.5%, higher than the "Ninth Five-Year Plan" plan of 15% of the target. Realize industrial added value of 57.8 billion yuan, an average annual growth rate of 15.5%. Pharmaceutical commercial sales totaled 150.9 billion yuan, an increase of 70.5 billion yuan over 1995, an average annual growth rate of 13.4%. The total import and export of pharmaceutical commodities amounted to 6.4 billion U.S. dollars, of which: exports of 3.8 billion U.S. dollars, an increase of 800 million U.S. dollars over 1995, an average annual growth rate of 4.8%, the pharmaceutical export-oriented economy is gradually taking shape. Pharmaceutical industry to achieve total profits and taxes 27 billion yuan, an increase of 15.5 billion yuan over 1995, an average annual growth rate of 18.6%, and realized profits of 14.38 billion yuan, an increase of 9.43 billion yuan over 1995, an average annual growth rate of 24.5%, have exceeded the "Ninth Five-Year Plan" to determine the target of 18%.
Three, pharmaceutical business profits of 760 million yuan, an increase of 400 million yuan over 1995, an average annual growth rate of 16.1%. Pharmaceutical industry has realized the benefits of growth faster than the total growth of the situation, the economic growth mode began to change. In 2009, the sales of the third terminal had reached 101.4 billion yuan, an increase of 26.7% year-on-year. In August 2010, the pharmaceutical industry revenue and total profit year-on-year growth rate of 25.69%, 34.71%.